Sunday, August 20, 2017

Positive Data on Forest Labs/Gedeon’s Cariprazine

April 1, 2014 by  
Filed under Depression

Forest Labs and partner Gedeon Richter's antipsychotic candidate, cariprazine, met the primary endpoint in a phase IIb study.

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!